Snowball logo
logo
MAZE

Maze Therapeutics, Inc. Common Stock

MAZE NASDAQ
$51.835+$1.395  (2.77%)

Frequently asked questions

What sector does Maze Therapeutics, Inc. Common Stock (MAZE) operate in?

Maze Therapeutics, Inc. Common Stock belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Maze Therapeutics, Inc. Common Stock (MAZE) current stock price?

As of the latest data, Maze Therapeutics, Inc. Common Stock stock price is $51.84, with a previous close of $50.44. Maze Therapeutics, Inc. Common Stock gained $1.40 in the last trading session, representing a 2.77% increase.

What is Maze Therapeutics, Inc. Common Stock (MAZE) current market capitalization?

Maze Therapeutics, Inc. Common Stock market cap is approximately 2.49 billion.

What is Maze Therapeutics, Inc. Common Stock (MAZE) Earnings Per Share (EPS)?

The trailing EPS is -$2.56, and the forward EPS is -$3.15.

What is Maze Therapeutics, Inc. Common Stock (MAZE) EBITDA?

Maze Therapeutics, Inc. Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -29.52 million.

Does Maze Therapeutics, Inc. Common Stock (MAZE) pay dividends?

No. Maze Therapeutics, Inc. Common Stock does not pay a dividend.

What is Maze Therapeutics, Inc. Common Stock (MAZE) beta (volatility) score?

Maze Therapeutics, Inc. Common Stock has a beta of 0.357, indicating lower volatility than the overall market.